JoVE Logo
Faculty Resource Center

Sign In

应用造血干细胞移植评估骨髓增生异常综合征的起源

DOI :

10.3791/58140-v

October 3rd, 2018

October 3rd, 2018

9,659 Views

1Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 2LGI Flow Cytometry Core Facility, Center for Cancer Research, National Cancer Institute, National Institutes of Health

我们描述了利用造血干细胞移植 (HSCT) 来评估基因工程造血细胞的恶性潜能。HSCT 可用于评估体内各种恶性造血细胞, 并产生大量小鼠骨髓增生异常综合征 (MDS) 或白血病, 以评估新的治疗方法。

Tags

140

-- Views

Related Videos

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved